期刊文献+

睡眠药物发展简史 被引量:3

Brief History of Sleep Drug Development
下载PDF
导出
摘要 良好的睡眠对人体健康至关重要,而遗传因素、环境刺激、疾病和药物等都会破坏睡眠-觉醒结构,导致睡眠障碍。近年来,随着社会的发展,生活压力逐渐加大,失眠的发病率呈上升并呈年轻化趋势。本文主要从促进睡眠的角度来简述睡眠药物发展的历史及当前研发聚焦的靶点,以助临床更好地了解镇静催眠药物并合理使用。 Good sleep is critical for human health.However,numerous factors will disturb the sleep-wake profile,such as heredity,environmental stimulus,diseases&drugs and so on,ultimately leading to sleep disorder.Too much sleep and lack of sleep are two main clinical manifestations,and the insomnia incidence is rising and shows younger trend with the development of society in recent years.We will briefly introduce the history of sleep-promoting medicine and the current targets for research and discovery,in order to help people know more about hypnotics and use them more rationally.
作者 章彬佳 邱子梁 张杰 ZHANG Binjia;QIU Ziliang;ZHANG Jie(Shanghai Haitian Pharmaceutical Technology Development Co.,Ltd.,Shanghai 200032,China)
出处 《世界睡眠医学杂志》 2020年第7期1169-1173,共5页 World Journal of Sleep Medicine
关键词 睡眠 药物发展 药物研发 Sleep Drug development Drug research and discovery
  • 相关文献

参考文献6

二级参考文献85

  • 1韩莹.扎来普隆的药理作用及应用[J].首都医药,2004,11(16):35-35. 被引量:1
  • 2李华芳,姚培芬,吕传真,孙学礼,高成阁,许秀峰,程能能,顾牛范.扎来普隆治疗失眠的随机、双盲双模拟、平行对照多中心临床试验[J].中国临床药学杂志,2005,14(3):138-142. 被引量:5
  • 3毛洪祥,王国强,杨碧秀.失眠症的临床研究进展[J].国际精神病学杂志,2006,33(1):1-4. 被引量:44
  • 4吴雅文,姜亚军.失眠的中医辨治[J].新疆中医药,2006,24(3):78-80. 被引量:10
  • 5Ota A,Masue T,Yasuda N,et al.Association between psychosocialjob characteristics and insomnia:an investigation using two relevantjob stress models—the demand-control-support(DCS)model andthe e ort-reward imbalance(ERI)model.Sleep Medicine,2005,6(4):353-358. 被引量:1
  • 6Neubauer DN.A review of ramelteon in the treatment of sleep dis-orders.Neuropsychiatric Disease and Treatment,2008,4(1):69-79. 被引量:1
  • 7Daley M,Morin CM,Leblanc M,et al.The Economic Burden ofInsomnia:Direct and Indirect Costs for Individuals with InsomniaSyndrome,Insomnia Symptoms,and Good Sleepers.Sleep,2009,32(1):55-64. 被引量:1
  • 8Higgins JPT,Green S.Cochrane Handbook for systematic Reviewsof Interventions Version 5.0.The Cochrane Collaboration,2008.Available at:www.Cochranehandbook.org. 被引量:1
  • 9Erman M,Seiden D,Zammit G,et al.An e cacy,safety,and dose-response study of Ramelteon in patients with chronic primary in- somnia.Sleep medicine,2006,7(1):17-24. 被引量:1
  • 10Richardson G,Wang-Weigand S.E ects of long-term exposure toramelteon,a melatonin receptor agonist,on endocrine function inadults with chronic insomnia.Human Psychopharm acology,2009,24(2):103-111. 被引量:1

共引文献784

同被引文献30

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部